
Loading, please wait...

Loading, please wait...

This study, involving 50 patients, found cryotherapy significantly more effective in reducing temperature in the upper extremity (12.5 °C) versus the lower extremity (9.6 °C), aiming to prevent chemotherapy-induced peripheral neuropathy (CIPN). Patients also showed better neurological test scores in their upper limbs. No significant differences in side effects were observed between extremities.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


This study, involving 50 patients, found cryotherapy significantly more effective in reducing temperature in the upper extremity (12.5 °C) versus the lower extremity (9.6 °C), aiming to prevent chemotherapy-induced peripheral neuropathy (CIPN). Patients also showed better neurological test scores in their upper limbs. No significant differences in side effects were observed between extremities.
2 months ago

As monsoon seasons elevate arboviral disease threats, Tamil Nadu has initiated an ICMR-monitored evaluation of the tetravalent dengue vaccine in Tenkasi district. Clinicians emphasize clinical monitoring, public prevention, and high-quality early pediatric care to reduce disease morbidity across endemic regions.
Today

A comparative cohort study evaluates vNOTES vs TLH hysterectomy for benign conditions, demonstrating shorter operative duration, faster return to daily activities, and equivalent female sexual function scores without increased dyspareunia.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today